|
Clinical and Laboratory Manifestations of Moderate Course of COVID-19
|
|
| Author:
|
IRODA SAMATOVA, AZIZA KHIKMATULLAEVA, ALLABERGAN BAYJANOV, MUAZZAM ABDUKADIROVA, NARGIZ IBADULLAEVA, NIGINA TADJIEVA
|
| Abstract:
|
This paper provides a comparative analysis of the clinical and laboratory parameters of the moderate course of
COVID-19 in Republic of Uzbekistan in March-April and October-November 2020 of the pandemic period.
For the late stage of the pandemic, compared with the early stage, the most frequent clinical symptoms of the
disease were weakness (92,4% and 85,0%), listlessness (88,6% and 6,25%), cough (81,0% and 68,7%), decreased
appetite (61,0% and 18,7%), increased body temperature (50,6% and 38,7%), anosmia (34,2% and 11,2%),
agenesis (38,0% and 12,5%), respectively. In 32,5% and 81,0% of the examined patients, respectively, the
disease proceeded with lung damage (pneumonia). The incidence of pneumonia was higher in the group of
patients receiving treatment in October-November 2020. Leukocytosis and an increased erythrocyte
sedimentation rate (ESR) were often (22,8% and 36,7%) observed in patients with bacterial communityacquired pneumonia.
|
| Keyword:
|
COVID-19, laboratory parameters, symptoms, inpatient treatment
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2021.13.03.029
|
| Download:
|
Request For Article
|
|
|